MX2017004909A - Composiciones de triptamina y metodos de uso. - Google Patents

Composiciones de triptamina y metodos de uso.

Info

Publication number
MX2017004909A
MX2017004909A MX2017004909A MX2017004909A MX2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A MX 2017004909 A MX2017004909 A MX 2017004909A
Authority
MX
Mexico
Prior art keywords
tryptamide
compositions
methods
tryptamides
eht extract
Prior art date
Application number
MX2017004909A
Other languages
English (en)
Inventor
Jose Fernandez
Stock Jeffry
Stock Maxwell
Voronkov Michael
HUBER Kristen
Original Assignee
Signum Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Signum Biosciences Inc filed Critical Signum Biosciences Inc
Publication of MX2017004909A publication Critical patent/MX2017004909A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Abstract

Extracto de EHT que incluye una mezcla de triptamidas de elución tardía y triptamidas de elución temprana en una proporción de peso de por lo menos aproximadamente 7:1 de triptamidas de elución tardía: triptamidas de elución temprana, en donde el extracto de EHT incluye por lo menos 30 % de eicosanoil-5-hidroxit riptamida, con base en el peso total de las triptamidas en el extracto de EHT.
MX2017004909A 2014-10-15 2015-10-15 Composiciones de triptamina y metodos de uso. MX2017004909A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462063983P 2014-10-15 2014-10-15
US201562121711P 2015-02-27 2015-02-27
PCT/US2015/055745 WO2016061357A1 (en) 2014-10-15 2015-10-15 Tryptamide compositions and methods of use

Publications (1)

Publication Number Publication Date
MX2017004909A true MX2017004909A (es) 2018-02-12

Family

ID=55747349

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004909A MX2017004909A (es) 2014-10-15 2015-10-15 Composiciones de triptamina y metodos de uso.

Country Status (13)

Country Link
US (1) US10314817B2 (es)
EP (1) EP3207029B1 (es)
JP (2) JP7179459B2 (es)
KR (1) KR20170066645A (es)
CN (1) CN107108495B (es)
AU (1) AU2015332434A1 (es)
CA (1) CA2963982C (es)
CO (1) CO2017004809A2 (es)
HK (1) HK1243404A1 (es)
MX (1) MX2017004909A (es)
PE (1) PE20171059A1 (es)
TW (1) TW201630882A (es)
WO (1) WO2016061357A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106565588A (zh) * 2016-11-10 2017-04-19 徐州工程学院 一种从坚果中提取食物源二十烷酸‑5‑羟色胺的方法
US20210369720A1 (en) * 2018-11-02 2021-12-02 Rutgers, The State University Of New Jersey Synergistic composition having neuroprotective properties and methods of use thereof
US11896600B2 (en) * 2019-09-21 2024-02-13 Vidya Herbs, Inc. Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639066A1 (de) * 1976-08-30 1978-03-02 Hag Ag Verfahren zur entfernung von reizstoffen aus kaffee
PT693547E (pt) * 1994-07-23 2001-07-31 Nestle Sa Composicao antioxidante e processo para a sua preparacao
JPH08157816A (ja) * 1994-12-02 1996-06-18 Oriza Yuka Kk 天然抗酸化剤およびその製造方法
AU2009239430B2 (en) * 2008-04-21 2015-01-22 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
DE202008005965U1 (de) * 2008-04-30 2008-12-11 Metsälä, Pertti Nahrungszusammensetzung
EP2382868A1 (en) 2010-04-30 2011-11-02 Tchibo GmbH Healthy coffee and method of its production
RU2569822C2 (ru) * 2010-10-13 2015-11-27 Интерконтинентал Грейт Брэндс ЛЛС Экстракты кофе в качестве ингредиентов пищевых продуктов, лекарств, косметических средств, пищевых добавок и биопрепаратов
WO2012121381A1 (ja) * 2011-03-10 2012-09-13 高砂香料工業株式会社 呈味改善剤
US8877766B2 (en) * 2013-02-15 2014-11-04 Peter F. Kador Neuroprotective multifunctional antioxidants and their monofunctional analogs

Also Published As

Publication number Publication date
CN107108495B (zh) 2021-07-16
CA2963982A1 (en) 2016-04-21
CO2017004809A2 (es) 2017-11-21
WO2016061357A1 (en) 2016-04-21
EP3207029A1 (en) 2017-08-23
AU2015332434A1 (en) 2017-04-20
CN107108495A (zh) 2017-08-29
JP2021059543A (ja) 2021-04-15
HK1243404A1 (zh) 2018-07-13
EP3207029B1 (en) 2021-08-04
US20170231955A1 (en) 2017-08-17
EP3207029A4 (en) 2018-05-02
JP2017531698A (ja) 2017-10-26
KR20170066645A (ko) 2017-06-14
US10314817B2 (en) 2019-06-11
CA2963982C (en) 2022-11-29
TW201630882A (zh) 2016-09-01
JP7179459B2 (ja) 2022-11-29
PE20171059A1 (es) 2017-07-21

Similar Documents

Publication Publication Date Title
MY191035A (en) Affinity-oligonucleotide conjugates and uses thereof
SG10201803042PA (en) Anti-tim-3 antibodies
MX2019007020A (es) Anticuerpos il-11.
WO2015200902A8 (en) Endophytes, associated compositions, and methods of use thereof
MX2019007021A (es) Anticuerpos il-11ra.
MX2019009842A (es) Composicion solida que comprende sofosbuvir amorfo.
MY191581A (en) Anti-pd-1 antibodies
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
WO2016044189A8 (en) Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
IL280809B (en) New preparations, their use and methods of their creation
MX2019010594A (es) Beta-caseina a2 y prevencion de la inflamacion del intestino.
MX2017008414A (es) Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
TN2017000435A1 (en) [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation
SG10201808278TA (en) Polishing composition and polishing method
MX2015008952A (es) Metodo para preparar fideos instantaneos, composicion de harina para fideo instantaneos y uso de la misma.
SG10201900598TA (en) Factor viii formulation
GB2576614B (en) Compositions, uses and methods
GB201804163D0 (en) Uses, compositions and methods
MX2016017142A (es) Dispersion solida de allisartan isoproxilo y composicion farmaceutica que comprende la misma.
MX2017004909A (es) Composiciones de triptamina y metodos de uso.
EP3140429A4 (en) Methods and compositions for scd, crt, crt-d, or sca therapy identification and/or selection
MX2017010526A (es) Mezclas de aceite, procesos para la preparacion de estas y su uso en formulas.
EP3307915A4 (en) PROBIOTIC COMPOSITION AS AUXILIARY AGENTS FOR LEATHER AND USE THEREOF